Eli Lilly's TuneLab AI platform reaches 100 members and integrates Chai's models

Eli Lilly has built TuneLab, an AI initiative that gives biotech companies free access to a range of artificial‑intelligence tools to support drug discovery and development.

The program recently announced that it has attracted a community of 100 member organizations, showing strong interest from the industry in leveraging Lilly's AI resources.

In addition, TuneLab has expanded its capabilities by adding AI models from the startup Chai, further broadening the suite of technologies available to its members.